1. Home
  2. CRDF vs TG Comparison

CRDF vs TG Comparison

Compare CRDF & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRDF
  • TG
  • Stock Information
  • Founded
  • CRDF 1999
  • TG 1988
  • Country
  • CRDF United States
  • TG United States
  • Employees
  • CRDF N/A
  • TG N/A
  • Industry
  • CRDF Biotechnology: Biological Products (No Diagnostic Substances)
  • TG Metal Fabrications
  • Sector
  • CRDF Health Care
  • TG Industrials
  • Exchange
  • CRDF Nasdaq
  • TG Nasdaq
  • Market Cap
  • CRDF 288.7M
  • TG 253.3M
  • IPO Year
  • CRDF N/A
  • TG 1989
  • Fundamental
  • Price
  • CRDF $3.79
  • TG $7.92
  • Analyst Decision
  • CRDF Strong Buy
  • TG
  • Analyst Count
  • CRDF 4
  • TG 0
  • Target Price
  • CRDF $12.00
  • TG N/A
  • AVG Volume (30 Days)
  • CRDF 1.2M
  • TG 99.0K
  • Earning Date
  • CRDF 05-01-2025
  • TG 03-12-2025
  • Dividend Yield
  • CRDF N/A
  • TG N/A
  • EPS Growth
  • CRDF N/A
  • TG N/A
  • EPS
  • CRDF N/A
  • TG N/A
  • Revenue
  • CRDF $683,000.00
  • TG $597,073,000.00
  • Revenue This Year
  • CRDF N/A
  • TG N/A
  • Revenue Next Year
  • CRDF N/A
  • TG N/A
  • P/E Ratio
  • CRDF N/A
  • TG $259.34
  • Revenue Growth
  • CRDF 39.96
  • TG 4.14
  • 52 Week Low
  • CRDF $2.01
  • TG $4.31
  • 52 Week High
  • CRDF $6.42
  • TG $9.22
  • Technical
  • Relative Strength Index (RSI)
  • CRDF 45.87
  • TG 59.84
  • Support Level
  • CRDF $3.65
  • TG $7.34
  • Resistance Level
  • CRDF $3.88
  • TG $7.76
  • Average True Range (ATR)
  • CRDF 0.30
  • TG 0.33
  • MACD
  • CRDF -0.03
  • TG 0.09
  • Stochastic Oscillator
  • CRDF 30.00
  • TG 92.97

About CRDF Cardiff Oncology Inc.

Cardiff Oncology Inc a clinical-stage biotechnology company leveraging PLK1 inhibition, a well-validated oncology drug target, to develop novel therapies across a range of cancers with the greatest unmet medical need. It is focusing on clinical program in indications such as RAS-mutated metastatic colorectal cancer ("mCRC"), as well as in investigator-initiated trials in metastatic pancreatic ductal adenocarcinoma ("mPDAC"), small cell lung cancer ("SCLC"), and triple negative breast cancer ("TNBC").

About TG Tredegar Corporation

Tredegar Corp through its subsidiaries engaged in the manufacture of Polyethylene Plastic films, Polyester Films, and Aluminum Extrusions. Polyethylene Plastic films manufacture plastic films, elastics and laminate materials which are utilized in personal care materials, surface protection films, and specialty and optical lighting applications. It operates through PE Films, Flexible Packaging Films, and Aluminum Extrusions segments. Aluminum Extrusions generates the majority of revenue and produces high-quality, soft-alloy, and medium-strength aluminum use for building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. It generates revenue from the United States, Asia, and Brazil.

Share on Social Networks: